Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-29
1996-10-01
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530380, 530395, 530415, 530416, 530830, C07K 118, C07K 122, C07K 1447, A61K 3817
Patent
active
055611087
ABSTRACT:
Human .alpha..sub.1 -antichymotrypsin (ACT) can be purified from solutions containing human .alpha..sub.1 -proteinase inhibitor (PI) and antithrombin III (AT-III) using chromatography adsorption steps at carefully controlled pH and conductivity. The separated ACT retains in vitro inhibitory capacity and has potential therapeutic use.
REFERENCES:
patent: 4379087 (1983-04-01), Coan et al.
patent: 5079336 (1992-01-01), Rubin et al.
Travis et al. Biochemistry 17(26) 5647-5651 1978.
Laine et al. Biochim Biophys Acta 668 429-438 1981.
Laine et al. Eur. J. Biochem 197 209-215 1991.
Laine et al Clin Chim Acta 190 163-174 1990.
Abdullah et al. Arch Biochem Biophys. 225(1) 306-312 1983.
Siddiqui et al Biochem Biophys Res. Commun. 95(4) 1737-1742 1980.
Bettencourt Jeffrey D.
Cheung Neal K. H.
Tsay Grace C.
Bayer Corporation
Degen Nancy J.
Fleisher Mindy
Giblin James A.
LandOfFree
Preparation of .alpha..sub.1 -antichymotrypsin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of .alpha..sub.1 -antichymotrypsin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of .alpha..sub.1 -antichymotrypsin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1501958